Pre-earnings brief
Reports
Fri, Nov 6, 2026
Est. EPS
—
Est. revenue
—
Implied move
±15.6%
EPS beat rate
88%
Humana Inc. is a leading health care company that provides managed health care services, including Medicare and Medicaid plans. With a market cap of $48 billion, it plays a crucial role in the health care sector, especially as the demand for health services continues to grow amid an aging population.
Last quarter
In Q2 2026, Humana reported an EPS of $7.61, significantly beating expectations by 22.27%. However, the stock fell 5.99% the following day, indicating market caution despite the strong earnings.
Management promises and guidance
EPS beat streak
4Q
EPS beat rate
88%
Avg EPS surprise
+9.64%
Avg 1-day reaction
+0.48%
Overall, analysts are cautiously optimistic about Humana's upcoming earnings, especially given its recent strong performance. However, there are concerns about rising costs and competition in the health care sector.
Bull case
If Humana continues to show strong EPS growth and membership expansion, it could signal robust demand for its services, potentially leading to a positive stock reaction.
Bear case
On the other hand, if the company reports lower-than-expected membership growth or higher costs, it could lead to significant downward pressure on the stock.
The print will turn on these.
Q1
What is the membership growth rate for Medicare Advantage plans?
This metric will be crucial in determining the company's future revenue potential and overall market position.
Q2
How has the Medical Loss Ratio changed compared to previous quarters?
A significant change in MLR could indicate shifts in operational efficiency and cost management, impacting profitability.
—
Est. EPS
$1.57
Est. Rev
$23.0B
Impl. Move
±5.7%
Why consensus could be wrong
The Street may be underestimating Humana's ability to manage costs effectively while expanding its membership base, particularly in the Medicare segment.
Supporting evidence
The company's recent EPS surprises indicate strong operational performance.
Options pricing suggests a higher expected move than historical averages, indicating potential for significant news.
Recent trends in health care spending could favor Humana's business model.
Key risk
If membership growth exceeds 5%, it could invalidate current bearish sentiment.
Pre-commit to what would confirm each case.
This quarter, the focus will be on how well Humana is managing costs while expanding its membership base.
Bull confirmed if
Membership growth of over 5% quarter-over-quarter would confirm the bull case.
Bear confirmed if
An MLR exceeding 85% could confirm the bear case.
What the market is pricing for the move.
Implied Move
±15.65%
Historical Avg
±5.2%
The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.
Options are pricing ±15.6% while HUM has averaged ±5.2% over the last 8 prints — setup is pricing rich.
ATM IV
0.7%
30d HV
29.9%
Cross-company pattern from 30 similar setups.
Prior-quarter beat + options rich in Health Care
Fade rate: 11 of 30 (37%)
This setup has occurred 30 times across Health Care in the last 2 years. 19 of 30 (63%) held or extended their move within 5 days — this setup typically holds direction. The average absolute 1-day move is 3.2%, with a raw directional average of -0.6% (modestly negative historical bias).
Smart-money positioning from the most recent 13F filings.
Institutional
100.95%
of float
Insider
0.21%
of float
Holders
1,304
institutions
Top Holders· as of Jun 2026
Dodge & Cox Inc.
10,940,380 sh · $4.3B
9.11%
-3.9%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Humana beats expectations, history suggests the stock could rise around 5.83%, confirming strong demand for its services.
In line / cautious
If results are in line with expectations, the stock may experience muted movement as investors await further guidance.
Miss
A miss could lead to a decline of about 12.40%, reflecting market disappointment and concerns over operational challenges.
The lines on the call that would change the story.
Blackrock Inc.
10,417,803 sh · $4.1B
8.68%
2.1%
Vanguard Capital Management LLC
7,843,620 sh · $3.1B
6.53%
0.1%
Vanguard Portfolio Management LLC
5,818,956 sh · $2.3B
4.85%
0.2%
State Street Corporation
5,457,072 sh · $2.2B
4.54%
0.1%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.